Summary
Lumbar cerebrospinal fluid (CSF) choline (CH) levels were measured in patients with Huntington's chorea (n = 14). This group was found not to differ significantly from normal controls (n = 13). The values for lumbar CSF Ch levels in the normal subjects were comparable with previously reported values. Of the choreic patients, seven were put on haloperidol treatment (4–6 mg daily). The CSF choline level remained unchanged with this treatment after 20 days. CSF cholinesterase activity was measured in the control and choreic group. The results were not significantly different.
Zusammenfassung
Im lumbalen Liquor cerebrospinalis wurde der Cholingehalt bei 14 Fällen von Huntington bestimmt. Im Vergleich zu 13 Gesunden wurden keine signifikanten Unterschiede gefunden. 7 Chorea-Patienten wurden mit Haloperidol 4–6 mg täglich behandelt. Der Cholingehalt des Liquors blieb auch nach Halloperidol über 20 Tage unverändert. Auch die Cholinesteraseaktivität im Liquor war bei Chorea-Kranken und Kontrollen unverändert
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Agid, Y.: Approche neuropharmacologique de la chorée de Huntington. Rev. Neurol. 131, 847–865 (1975)
Aquilonius, S. M., Nyström, B., Schuberth, J., Sundwall, A.: Cerebrospinal fluid choline in extrapyramidal disorders. J. Neurol. Neurosurg. Psychiat. 35, 720–725 (1972)
Aquilonius, S. M., Schuberth, J., Sundwall, A.: Choline in the cerebrospinal fluid as a marker for the release of acetylcholine. In: Heilbronn and Winter Drugs and Cholinergic Mechanisms in the CNS, pp. 399–410. Stockholm: Research Institute of National Defense 1970
Bird, E. D., Iversen, L. L.: Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97, 457–472 (1974)
Bowers, M. B. Jr.: Choline in cerebrospinal fluid. Life Sci. 6, 1927–1933 (1967)
Bruyn, G.W.: Huntington's chorea: Historical clinical and laboratory synopsis. In: Vinken and Bruyn Handbook of Clinical Neurology, Vol. 6, pp. 298–378. New York: American Elsevier 1968
Bruyn, G. W.: Neuropathology changes in Huntington's chorea. In: Barbeau, Chase and Paulson Advances in Neurology, Vol. 1, pp. 399–403. New York: Raven Press 1973
Caraceni, T., Calderini, G., Consolazione, A., Riva, E., Algeri, S., Girotti, F., Spreafico, R., Branciforti, A., Dall'Olio, A., Morselli, P. L.: Biochemical aspects of Huntington's Chorea (clinico-biochemical correlations). J. Neurol. Neurosurg. Psychiat. (in press)
Cotzias, G. C., Van Woert, M. H., Schiffer, L. M.: Aromatic amino acids and modification of Parkinsonism. New Engl. J. Med. 276, 374–379 (1967)
Duvoisin, R. C.: Cholinergic-anticholinergic antagonism in Parkinson. Arch. Neurol. 17, 124–136 (1967)
Duvoisin, R. C., Dettborn, W. D.: Cerebrospinal fluid acetylcholine in man. Neurology, Minneap. 17, 1077–1081 (1967)
Ehringer, H., Hornykiewicz, O.: Distribution of noradrenaline and dopamine (3-hydroxytryptamine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 38, 1236–1239 (1960)
Enna, J., Bird, E. D., Bennett, J. P., Jr., Bylund, D. B., Yamamura, H. I., Iversen, L. L., Snyder, S. H.: Huntington's chorea: Changes in neurotransmitter receptors in the brain. New Engl. J. Med. (in press, 1976)
Guyenet, P. G., Agid, Y., Javoy, F., Beaujouan, J. C., Rossier, J., Glowinski, J.: Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system. Brain Res. 84, 227–244 (1975)
Hiley, C. R., Bird, E. D.: Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea. Brain Res. 80, 355–358 (1974)
Hornykiewicz, O.: Dopamine (3-hydroxytryptamine) and brain function. Pharmacol. Reviews 18, 925–964 (1966)
Klawans, H. L., Jr., Rubowits, R.: Central cholinergic-anticholinergic antagonism in Huntington's chorea. Neurology, Minneap. 22, 107–116 (1972)
Ladinsky, H., Consolo, S., Bianchi, S., Jori, A.: Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabergic-dopaminergic-cholinergic link. Brain Res. 108, 351–361 (1976)
Ladinsky, H., Consolo, S., Bianchi, S., Samanin, R., Ghezzi, D.: Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine. Brain Res. 84, 221–226 (1975)
McCaman, M. W., Tomey, L. R., McCaman, R. E.: Radiometric assay of acetylcholinesterase activity in submicrogram amounts of tissue. Life Sci. 7, 233–244 (1968)
McGeer, P. L., McGeer, E. G., Fibiger, H. C.: Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. Neurology, Minneap. 23, 912–917 (1973)
Saelens, J. K., Allen, M. P., Simke, J. P.: Determination of acetylcholine and choline by an enzymatic assay. Arch. Internat, de Pharmacodynamie et de Thérapie 186, 279–286 (1970)
Schuberth, J., Jenden, D. J.: Transport of choline from plasma to cerebrospinal fluid in the rabbit with reference to the origin of choline and to acetylcholine metabolism in brain. Brain Res. 84, 245–256 (1975)
Stadler, H., Lloyd, K. G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)
Stahl, W. L., Swanson, P. D.: Biochemical abnormalities in Huntington's chorea brains. Neurology, Minneap. 24, 813–819 (1974)
Trabucchi, M., Cheney, D., Racagni, G., Costa, E.: Involvement of brain cholinergic mechanism in the action of chlorpromazine. Nature 249, 664–666 (1974)
Welch, M. J., Markham, C. H., Jenden, D. J.: Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea. J. Neurol. Neurosurg. Psychiat. 39, 367–374 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Consolo, S., Ladinsky, H., Bianchi, S. et al. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Arch. Psychiat. Nervenkr. 223, 265–270 (1977). https://doi.org/10.1007/BF00342343
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00342343